Replies to post #121778 on Biotech Values

[BTH]

Please tell me where the fundamentals have changed in the story.

The "fundamental" analysis before the banking implosions didn't tell the whole story in the Lehman Debacle but the technicals certainly were "foretelling" the story. Heck, people were still pounding the table on Lehman and Bear even after the dropped 65-75%.

My whole point is something is obviously wrong with something at the company...for it to have just lost about 30% its value in the past couple of months, and an ever evaporating market-cap. And, it's not obvious what it is.

If ARRY dips below $2, I may consider adding again

LOL. If you loved it at $3, you gotta love it at $2. And, if you really loved it at $2, you're gonna really love the thing at $1.00....etc etc etc.

Has AZN or NVS/ARRY presented some negative data that I missed

You and I might have missed it because we haven't paid consulting fees to doctors in the study....